Top Banner
Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD
42

Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Apr 01, 2015

Download

Documents

Reuben Hamley
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Risk Reduction in Sedation and Analgesia

Risk Reduction in Sedation and Analgesia

Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD

Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD

Page 2: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

OverviewOverview

Complications occur because of:

Inappropriate patient selection

Unanticipated responses from patient or

equipment

Over-medication

Wrong patient/wrong site/wrong procedure

Complications occur because of:

Inappropriate patient selection

Unanticipated responses from patient or

equipment

Over-medication

Wrong patient/wrong site/wrong procedure

Page 3: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Strategies to reduce risk,‘patient selection’

Strategies to reduce risk,‘patient selection’

Improve patient selection

ASA Classification

airway assessment and history

identify other factors e.g. pregnancy, obesity

Improve patient selection

ASA Classification

airway assessment and history

identify other factors e.g. pregnancy, obesity

Page 4: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Patient SelectionPatient Selection

Important ‘baseline’ assessments are: actual or estimated weight vital signs including baseline oxygen

saturation cardiopulmonary status general neurological status previous adverse responses to medication

(not just allergy detection)_ ASA classification (Baseline airway evaluation)

Important ‘baseline’ assessments are: actual or estimated weight vital signs including baseline oxygen

saturation cardiopulmonary status general neurological status previous adverse responses to medication

(not just allergy detection)_ ASA classification (Baseline airway evaluation)

Page 5: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

ASA ClassificationASA Classification

ASA 1 Normal, healthy patient ASA 2Stable mild systemic disease ASA 3Severe systemic disease with

functional impairment ASA 4Severe disease, constant threat

to life, not necessarily to be improved by surgery

ASA 5Moribund patient, not expected to survive without

surgery ASA 6Brain-dead donor Emergency (E)

ASA 1 Normal, healthy patient ASA 2Stable mild systemic disease ASA 3Severe systemic disease with

functional impairment ASA 4Severe disease, constant threat

to life, not necessarily to be improved by surgery

ASA 5Moribund patient, not expected to survive without

surgery ASA 6Brain-dead donor Emergency (E)

Page 6: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Patient SelectionPatient Selection

All patients should be carefully

evaluated by the MD. Some ASA Class

III, and most ASA Classes IV and V will

not be suitable for sedation

administered by non-anesthesiologists.

All patients should be carefully

evaluated by the MD. Some ASA Class

III, and most ASA Classes IV and V will

not be suitable for sedation

administered by non-anesthesiologists.

Page 7: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Mallampati classificationMallampati classification

Page 8: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Airway AssessmentAirway Assessment

Mallampati classificationNeck extensionThyromental distance (?short neck)Interincisor distance (?poor mouth opening)Concurrent obesity(History of airway problems)

Letters and bracelets

Page 9: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Patient SelectionPatient Selection

Anesthesia consultation should also be considered under the following circumstances: patient has limited neck motion or cervical

instability patient has abnormal craniofacial anatomy patient is morbidly obese patient has a history of sleep apnea pregnant patients patient has not been NPO

Anesthesia consultation should also be considered under the following circumstances: patient has limited neck motion or cervical

instability patient has abnormal craniofacial anatomy patient is morbidly obese patient has a history of sleep apnea pregnant patients patient has not been NPO

Page 10: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Strategies to reduce risk,‘unanticipated events’

Strategies to reduce risk,‘unanticipated events’

Have available and be familiar with essential pieces of equipment basic interpretation of ECG understand pulse oximetry and know the

limitations of use capnography reliable oxygen source, equipment for

positive pressure ventilation know how to quickly and reliably get help

Have available and be familiar with essential pieces of equipment basic interpretation of ECG understand pulse oximetry and know the

limitations of use capnography reliable oxygen source, equipment for

positive pressure ventilation know how to quickly and reliably get help

Page 11: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Ideal Patient PositioningIdeal Patient Positioning

Page 12: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Obstructed AirwayObstructed Airway

Page 13: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Oral AirwayOral Airway

Page 14: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Nasal AirwayNasal Airway

Page 15: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Mask VentilationMask Ventilation

Page 16: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

EtCO2 ApparatusEtCO2 Apparatus

Page 17: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

EtCO2 TracingEtCO2 Tracing

Page 18: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Unanticipated eventsUnanticipated events

Cardiac instability/dysrhythmia

Respiratory depression and/or airway

obstruction

Neurological ‘disconnection’

Equipment malfunction

Cardiac instability/dysrhythmia

Respiratory depression and/or airway

obstruction

Neurological ‘disconnection’

Equipment malfunction

Page 19: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Unanticipated cardiovascular events

Unanticipated cardiovascular events

Cardiovascular instability Hypotension Tachycardia PVC’s atrial arrhythmias ventricular

arrhythmias cardiac arrest!

Cardiovascular instability Hypotension Tachycardia PVC’s atrial arrhythmias ventricular

arrhythmias cardiac arrest!

Possible causes hypovolemia allergic reaction overmedication hypoxemia ischemia hypercarbia bleeding

Possible causes hypovolemia allergic reaction overmedication hypoxemia ischemia hypercarbia bleeding

Page 20: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Unanticipated respiratory events

Unanticipated respiratory events

Respiratory complications depression

airway

obstruction

bronchospasm

Respiratory complications depression

airway

obstruction

bronchospasm

Possible causes

overmedicationrelative

absolute

patient position

‘foreign material’

allergic reaction

Possible causes

overmedicationrelative

absolute

patient position

‘foreign material’

allergic reaction

Page 21: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Unanticipated neurological events

Unanticipated neurological events

Neurological ‘Disconnection’ drowsiness unresponsiveness uncooperative combative disinhibition

Neurological ‘Disconnection’ drowsiness unresponsiveness uncooperative combative disinhibition

Possible causes overmedication Hypoxemia hypercarbia cerebral ischemia

hypoxemiacerebral

hypoperfusion undermedication?

Possible causes overmedication Hypoxemia hypercarbia cerebral ischemia

hypoxemiacerebral

hypoperfusion undermedication?

Page 22: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Unexpected events:The catastrophe!

Unexpected events:The catastrophe!

Call for help/Code BlueDiscontinue sedative therapy,

infusions /transfusions etcBegin BCLS/ACLS if appropriateprepare emergency equipment, drugstry to anticipate resuscitation needs

Call for help/Code BlueDiscontinue sedative therapy,

infusions /transfusions etcBegin BCLS/ACLS if appropriateprepare emergency equipment, drugstry to anticipate resuscitation needs

Page 23: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Equipment problems:E.C.G.

Equipment problems:E.C.G.

Problems

No trace/loss of

trace

Poor quality

Intermittent trace

Interference

Problems

No trace/loss of

trace

Poor quality

Intermittent trace

Interference

Possible causes ASYSTOLE!! loose leads incorrect placement dry electrodes! greasy skin respiratory variation electrical interference

Possible causes ASYSTOLE!! loose leads incorrect placement dry electrodes! greasy skin respiratory variation electrical interference

Page 24: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Equipment problems:Non-invasive BP

Equipment problems:Non-invasive BP

Problems

no reading

repetitive cycling

very low/high BP

??Arterial line

Problems

no reading

repetitive cycling

very low/high BP

??Arterial line

Possible causes: HYPOTENSION! HYPERTENSION! cuff leak wrong size cuff arrhythmia e.g. AF tubing kinked patient/MD movement

Possible causes: HYPOTENSION! HYPERTENSION! cuff leak wrong size cuff arrhythmia e.g. AF tubing kinked patient/MD movement

Page 25: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Equipment problems:Pulse oximetry

Equipment problems:Pulse oximetry

Problems:

no reading

low reading

intermittent trace

frequent alarm

Problems:

no reading

low reading

intermittent trace

frequent alarm

Possible causes no pulse! hypoxemia! decreased perfusion dye injection electrical interference inappropriate sat/pulse

settings incident light/nail polish

Possible causes no pulse! hypoxemia! decreased perfusion dye injection electrical interference inappropriate sat/pulse

settings incident light/nail polish

Page 26: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Equipment problems:Pulse oximetry

Equipment problems:Pulse oximetry

REMEMBER! Oximetry does not measure respiration there may be a lag phase, depending on

probe site

as with all the equipment:

if it isn’t working at the beginning it will

not suddenly get better, it is likely to let

you down when you need it most.

REMEMBER! Oximetry does not measure respiration there may be a lag phase, depending on

probe site

as with all the equipment:

if it isn’t working at the beginning it will

not suddenly get better, it is likely to let

you down when you need it most.

Page 27: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Strategies to reduce risk,‘over-sedation’

Strategies to reduce risk,‘over-sedation’

Have an understanding of the pharmacology involved in conscious sedation Titrate drugs carefully to patient weight but

especially to effect. Have appropriate reversal agents readily

available and know how to use them Know where other emergency drugs can

be found

Have an understanding of the pharmacology involved in conscious sedation Titrate drugs carefully to patient weight but

especially to effect. Have appropriate reversal agents readily

available and know how to use them Know where other emergency drugs can

be found

Page 28: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Commonly Used MedicationsCommonly Used Medications

Midazolam intravenous/oral/intramuscular/intranasal Initial dose 0.5-2mg iv over 2 min Onset 1minute, peak 3-5 mins Wait full 2 mins between doses with 0.5-

1mg increments Duration 1-2 hours

Midazolam intravenous/oral/intramuscular/intranasal Initial dose 0.5-2mg iv over 2 min Onset 1minute, peak 3-5 mins Wait full 2 mins between doses with 0.5-

1mg increments Duration 1-2 hours

Page 29: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Commonly Used MedicationsCommonly Used Medications

Valium Initial dose 2-5 mg iv Onset 1-5 mins Wait full 5 mins between doses with 1 mg

increments Duration 3-4 hours

Valium Initial dose 2-5 mg iv Onset 1-5 mins Wait full 5 mins between doses with 1 mg

increments Duration 3-4 hours

Page 30: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Commonly Used MedicationsCommonly Used Medications

FentanylOnset 1-3 min; peak-effect at 3-5

minutes Initial dose 25-50 mcg iv titrated in 25mcg doseslow dose drug is short actingDuration of effect 30-60 mins

FentanylOnset 1-3 min; peak-effect at 3-5

minutes Initial dose 25-50 mcg iv titrated in 25mcg doseslow dose drug is short actingDuration of effect 30-60 mins

Page 31: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Commonly Used MedicationsCommonly Used Medications

MorphineOnset 1-6 minInitial dose 2-5 mg iv titrated in 2 mg doses but wait 3-5 mins

between dosesDuration of effect 3-5 hours

MorphineOnset 1-6 minInitial dose 2-5 mg iv titrated in 2 mg doses but wait 3-5 mins

between dosesDuration of effect 3-5 hours

Page 32: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Commonly Used MedicationsCommonly Used Medications

MeperidineInitial dose 25-50 mg ivOnset 2-8 mins, peak 20 minsMild vagolytic and antispasmodicNormeperidine is pro-convulsantDose titration 12.5-25mg; Duration 2-

3hrsInteraction with MAOIs

MeperidineInitial dose 25-50 mg ivOnset 2-8 mins, peak 20 minsMild vagolytic and antispasmodicNormeperidine is pro-convulsantDose titration 12.5-25mg; Duration 2-

3hrsInteraction with MAOIs

Page 33: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

OvermedicationOvermedication

Why does overmedication occur? Excessive dose Overly sensitive patient,

concurrent medications or disease states Inadequate time for effect before more

drug administered Abnormal response such as hyperactivity

leading to more medication

Why does overmedication occur? Excessive dose Overly sensitive patient,

concurrent medications or disease states Inadequate time for effect before more

drug administered Abnormal response such as hyperactivity

leading to more medication

Page 34: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

OvermedicationOvermedication

What problems does overmedication cause? Airway obstruction Hypoxemia and hypercarbia Loss of protective reflexes Loss of contact with the caregiver Hemodynamic instability Interferes with the procedure

What problems does overmedication cause? Airway obstruction Hypoxemia and hypercarbia Loss of protective reflexes Loss of contact with the caregiver Hemodynamic instability Interferes with the procedure

Page 35: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

OvermedicationOvermedication

How may overmedication be managed? stop medicating! open airway and stimulate to breathe ensure adequate oxygen supply call for help early, especially if

hemodynamic instability consider reversal of medication have suction immediately available

How may overmedication be managed? stop medicating! open airway and stimulate to breathe ensure adequate oxygen supply call for help early, especially if

hemodynamic instability consider reversal of medication have suction immediately available

Page 36: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

OvermedicationOvermedication

How may medication be reversed?

Opiates and benzodiazepines are the only

drugs with specific antagonists:

REMEMBER: once reversal agents are

used this MUST lead to a longer period of

post-procedure monitoring.

How may medication be reversed?

Opiates and benzodiazepines are the only

drugs with specific antagonists:

REMEMBER: once reversal agents are

used this MUST lead to a longer period of

post-procedure monitoring.

Page 37: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Reversal AgentsReversal Agents

NALOXONE, 40mcg - 400mcg slow I.V.

Onset 1-3 minutes, duration 45 minutes

will reverse analgesia

may cause pulmonary edema

beware withdrawal effects if long term narcotic use

may need repeating or infusion

NALOXONE, 40mcg - 400mcg slow I.V.

Onset 1-3 minutes, duration 45 minutes

will reverse analgesia

may cause pulmonary edema

beware withdrawal effects if long term narcotic use

may need repeating or infusion

Page 38: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

Reversal AgentsReversal Agents

FLUMAZENIL, 0.1mg - 0.2 mg I.V. for partial reversal0.4mg - 1.0mg I.V. for complete reversalOnset 1-2 minutes, duration 45 minutesmay precipitate withdrawal seizurenot to be used routinelyhalf life of benzodiazepine may be long so

flumazenil may need to be repeated

FLUMAZENIL, 0.1mg - 0.2 mg I.V. for partial reversal0.4mg - 1.0mg I.V. for complete reversalOnset 1-2 minutes, duration 45 minutesmay precipitate withdrawal seizurenot to be used routinelyhalf life of benzodiazepine may be long so

flumazenil may need to be repeated

Page 39: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.
Page 40: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.
Page 41: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.
Page 42: Risk Reduction in Sedation and Analgesia Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD Rowland P. Wu, MD Adapted from Glynne D. Stanley, MD.

SummarySummary

Choose your patients carefully.

Check and understand your equipment

Use medication judiciously, you can’t take it out but you can always give more!

Have reversal agents available but remember basic airway techniques.

Be vigilant and prepare for the unexpected.

Choose your patients carefully.

Check and understand your equipment

Use medication judiciously, you can’t take it out but you can always give more!

Have reversal agents available but remember basic airway techniques.

Be vigilant and prepare for the unexpected.